dabrafenib,trametinib
novartis
['melanoma', 'congrat', 'dabrafenib', 'trametinib']
congratulations also to melanoma fellow as she presents important data regarding the use of second adjuvant dabrafenib/trametinib in those who recur despite adjuvant pd1. #asco22 
Medical Oncologist, Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals. Opinions my own.